Moderna
MRNA
#1020
Rank
A$29.13 B
Marketcap
$75.72
Share price
-2.95%
Change (1 day)
-33.90%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of June 2024 : A$12.78 Billion

According to Moderna 's latest financial reports the company has A$12.78 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$12.62 B-13.21%
2022-12-31A$14.55 B-1.66%
2021-12-31A$14.79 B146.9%
2020-12-31A$5.99 B280.4%
2019-12-31A$1.57 B-27.05%
2018-12-31A$2.15 B123.01%
2017-12-31A$0.96 B-34.03%
2016-12-31A$1.46 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.14 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.09 B 33.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.53 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.18 B-67.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.11 B 65.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.65 B-94.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.56 B 139.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA